Search - tctmd.com

Displaying 21 - 40 of 103

Sort: Relevancy | Date

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

Presentation TCT 2019

Acute Cardiogenic Shock: The Number One Unresolved Challenge in Cardiovascular Disease

Presenter: William O'Neill

September 27, 2019

Presentation TCT 2019

Current Landscape and Future Directions: Percutaneous Ventricular Assist Devices

Presenter: William O'Neill

September 25, 2019

Presentation CHIP Seattle 2019

All Patients With Ami Cardiogenic Shock Should Receive Advanced Mechanical Circulatory Support

Presenter: William W. O’Neill

August 02, 2019

News Daily News

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

Yael L. Maxwell

July 11, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

Caitlin E. Cox

December 11, 2018

Presentation TCT 2018

AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device

Presenter: Jonathan M. Hill, E. Magnus Ohman, William W. O'Neill

September 22, 2018

Presentation TCT 2018

Use of Impella (CP and RP) in Cardiogenic Shock: From Hemodynamics to Clinical Outcomes

Presenter: Cindy L. Grines, E. Magnus Ohman, William W. O'Neill

September 22, 2018

Presentation TCT 2018

Interventional Management of Cardiogenic Shock: Clinical Indications and Therapeutic Options

Presenter: William W. O'Neill

September 21, 2018

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

Caitlin E. Cox

April 12, 2018

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Conference News ACC 2017

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

Todd Neale

March 22, 2017

Presentation TCT 2016

The Impella Family of Devices: Utility of Different Tools for Different Conditions

Presenter: David E. Kandzari, Navin K. Kapur, William W. O'Neill

November 01, 2016

Presentation TCT 2016

Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation

Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, William W. O'Neill

November 01, 2016

Presentation TCT 2016

Staying in Medicine: Potential Options

Presenter: David O. Williams, William W. O'Neill

November 01, 2016

Presentation TCT 2016

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Presenter: Ulrich P. Jorde, William W. O'Neill, Adam B. Greenbaum

October 31, 2016

Advertisement

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Acute Cardiogenic Shock: The Number One Unresolved Challenge in Cardiovascular Disease

Current Landscape and Future Directions: Percutaneous Ventricular Assist Devices

All Patients With Ami Cardiogenic Shock Should Receive Advanced Mechanical Circulatory Support

Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

AMICS: Predictors of Survival in Patients With Acute Myocardial Infarction and Cardiogenic Shock Supported With a Percutaneous Left Ventricular Assist Device

Use of Impella (CP and RP) in Cardiogenic Shock: From Hemodynamics to Clinical Outcomes

Interventional Management of Cardiogenic Shock: Clinical Indications and Therapeutic Options

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Prioritizing Impella Support May Boost Cardiogenic Shock Survival, Pilot Study Suggests

The Impella Family of Devices: Utility of Different Tools for Different Conditions

Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation

Staying in Medicine: Potential Options

Novel Access Approaches for Percutaneous Maximal Circulatory Support Devices: Transcaval and Subclavian/Axillary Advancements

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content